Instituto de Investigación Biomédica de Salamanca-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2024

  1. Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3

    Biomedicine and Pharmacotherapy, Vol. 180

2023

  1. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  2. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

2022

  1. Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 27, pp. 3151-3161

  2. Environmental drivers of the seasonal exposure to airborne Alternaria spores in Spain

    Science of the Total Environment, Vol. 823

  3. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2020

  1. Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis

    Cells, Vol. 9, Núm. 3

2019

  1. YRNAs overexpression and potential implications in allergy

    World Allergy Organization Journal, Vol. 12, Núm. 8

2014

  1. Genome-wide expression profiling of B lymphocytes reveals IL4R increase in allergic asthma

    Journal of Allergy and Clinical Immunology, Vol. 134, Núm. 4, pp. 972-975

  2. Polycystic liver diseases: Advanced insights into the molecular mechanisms

    Nature Reviews Gastroenterology and Hepatology, Vol. 11, Núm. 12, pp. 750-761